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ABSTRACT
Objective: Hypertension is a multifactorial disease and it is a common disorder worldwide. This study was conducted to identify the effectiveness of 
cardiac walking on blood pressure (BP) among patients with hypertension at a selected hospital in Kancheepuram district.
Methods: A quasi-experimental pre- and post-test with comparison group design was chosen for this study. Using purposive sampling technique, 
a total of 50 samples were recruited for the study which included 25 each in study and comparison groups. Pre-test was done using a structured 
instrument that included demographic, biological, and clinical variables, and BP was measured by stethoscope and sphygmomanometer. Cardiac 
walking was implemented for the study group participants whereas comparison group participants were on routine care. Post-test was done for both 
the study and comparison group participants. Both descriptive and inferential statistics were used for the analysis.
Results: The paired t-test revealed the statistically significant difference between pre- and post-test systolic and diastolic BP within the study group 
participants at level p<0.001 whereas there was no significant difference among comparison group participants. The independent t-test unveiled the 
statistically significant difference between the study and comparison group participants in BP at level p<0.001.
Conclusion: These study findings implied that the simple measure cardiac walking is cost-effective to maintain the BP within normal limit for patients 
with hypertension throughout their survivorship.
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INTRODUCTION
“Hypertension is a silent killer but preventable.”
The current lifestyle pattern of human beings is assiduous and diligent 
to keep in pace with the tremendous changes in their work schedule. 
This mounts enormous pressure and creates health problems. In the 
contemporary world, one of the common lifestyle-related health problems 
is hypertension which is also known as high or raised blood pressure (BP). 
It is a major global public health issue. A combination of lifestyle factor 
increases the risk of non-communicable disorders, especially increases 
the resistance of blood flow through the arteries leading to high BP.
Globally, the overall prevalence of raised BP in adults aged 25 years 
and over was around 40% in 2008 (World Health Organization 
[WHO]). The proportion of the world’s population with high BP, or 
uncontrolled hypertension, fell modestly between 1980 and 2008 [1]. 
The study conducted by the Indian Council of Medical Research (2014) 
in Tamil Nadu, Maharashtra, Jharkhand, and Chandigarh unveiled that 
the prevalence of hypertension was highest in Tamil Nadu at 27.6%, 
followed by Chandigarh at 25.8%, Maharashtra at 25%, and Jharkhand 
at 23%. While overall, the prevalence of hypertension was more in 
urban areas than in rural areas [2]. According to the WHO (2012), 
hypertension is the number one cause of mortality in the world and it is 
a major risk factor for cardiac diseases and stroke [3]. The progressively 
higher BP leads to end-stage renal disease. Hence, to investigate the 
simple measure to reduce BP, a study was conducted with an objective 
of determination of the effect of cardiac walking on BP among patients 
with hypertension.
METHODS
A quantitative research approach of quasi-experimental pre- and 
post-test with comparison group design was chosen for this study. 
A total of 50 samples were recruited using purposive sampling 
technique which composed of 25 each in study (n=25) and 
comparison groups (n=25). Ethical approval was obtained from 
the Institutional Ethical Committee from the selected hospital at 
Kancheepuram district, and informed consent was obtained from 
all the samples. Patients who were male and diagnosed to have 
hypertension, who were ambulatory and aged between 35 and 
45 years, and able to talk and understand Tamil or English were 
included for the study.
Patients who had impaired physical mobility in the lower limbs and 
unable to walk, mentally challenged, disoriented, and unable to follow 
the instructions, who were diagnosed to have congestive cardiac failure, 
valvular disorders, and cardiomyopathy, who had edema in the lower 
limb, and who were regularly practicing yoga and/or exercises were 
excluded from the study.
The structured tools included were Part I, II, III, and IV.
•	 Part	 I:	Demographic variables which were obtained by interview 
method. It was designed with nine items that included age, marital 
status, religion, education, occupation, and dietary pattern, history 
of smoking, history of alcoholism, and history of chewing tobacco
•	 Part	 II:	 Biological	 variables	were	 obtained	 by	 anthropometric	
measurements and interview method. It encompassed height, weight, 
body mass index, waist circumference, and sleeping pattern
•	 Part	III:	Clinical	variables were collected by clinical record survey 
which included comorbidity, time since diagnosis, name of the anti-
hypertensive medication, duration of treatment, blood glucose level, 
and total cholesterol level
•	 Part	IV:	Consisted	of	assessment	of	BP	(mmHg)	using	stethoscope	
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Data collection procedure
The data were obtained using structured instrument Part I, II, III, 
and IV in pre-test and only Part IV was obtained in post-test for both 
the study and comparison group participants. The study design was 
divided into pre-test on day 1 for study and comparison groups, cardiac 
walking for 7 days with routine treatment for study group, only routine 
treatment for comparison group, and post-test on day 8 for both the 
group participants. Cardiac walking was taught for the study group 
participants that encompassed three phases, namely,
•	 Phase	I:	Warm	up	–	It	involved	5-10	minutes	of	low	intensity	walking
•	 Phase	II:	10-15	minutes	of	moderate	intensity	walking
•	 Phase	III:	Cool	down,	 this	 included	5-10	minutes	of	 low	intensity	
walking.
The study group participants were given audio-visual session regarding 
general information about hypertension (definition, causes/risk 
factors, normal systolic and diastolic BP values, management, and 
complications) and demonstration of cardiac walking by the investigator 
after pre-test on day 1, whereas comparison group participants were on 
routine care that was only antihypertensive medications. Post-test was 
done for both group participants on day 8.
Statistical analysis
The data were analyzed by Statistical Package for Social Sciences 
version 16. The paired t- and independent t-tests were computed to 
find the difference in BP within and between the study and comparison 
groups, respectively.
The hypothesis “H1:	There	is	a	significant	difference	in	the	systolic	and	
diastolic BP among patients with hypertension who had subjected to 
cardiac walking than those who had not” was tested in this study.
RESULTS
Age-wise distribution showed that 8 (32%) participants in study and 
comparison groups each were aged between 35 and 37 years whereas 
7 (28%) participants in each group were aged between 38 and 40 years. 
Out of 50 samples, 12 (48%) study group participants had the habit of 
chewing tobacco against 8 (32%) in comparison group (Table 2).
With respect to the body mass index classification, 12 (48%) 
participants in study group and 17 (68%) in comparison group were 
classified as overweight. Out of 25 participants each in study and 
comparison groups, 9 (36%) and 16 (64%) participants, respectively, 
had the waist circumference ranging from 85.1 to 90 cm (Table 3).
With reference to the total cholesterol, 13 (52%) study group 
participants had the value between 191 and 200 mg/dl against 
comparison group participants of 15 (60%) (Table 4).
The distribution of level of BP in pre- and post-test among study group 
participants revealed that all the 25 (100%) study group participants 
had Stage 1 systolic and diastolic hypertension in the pre-test, whereas 
in post-test, 22 (88%) and 25 (100%) participants had pre-hypertension 
systolic and pre-hypertension diastolic, respectively. Only 1 (4%) 
participant had Stage 1 hypertension systolic in the post-test (Table 5).
The distribution of level of BP in the pre- and post-test among 
comparison group showed that all the 25 (100%) comparison group 
participants had the Stage 1 systolic and diastolic hypertension in the 
pre-test, whereas in the post-test, 23 (92%) had Stage 1 systolic and 
diastolic hypertension. About 2 (8%) participants progressed to Stage 2 
systolic and diastolic hypertension in the post-test (Table 6).
The comparison of pre- and post-test systolic and diastolic BP within 
the study group depicted statistically significant difference at p<0.001. 
The comparison of pre- and post-test systolic and diastolic BP within 
comparison group illustrated no statistically significant difference 
(Table 7).
The comparison of post-test systolic and diastolic BP between study 
and comparison groups inferred that there was a statistically significant 
difference at a level of p<0.001 (Table 8).
DISCUSSION
Hypertension is the common disorder worldwide affecting larger 
population. The mortality and morbidity rate of patients with 
hypertension are steadily increasing and pose the greatest threat to the 
health-care system.
The distribution of level of BP in pre-test unveiled that all 25 (100%) 
participants each in study and comparison groups had Stage 1 systolic 
and diastolic hypertension in the pre-test, whereas in the post-test, 
22 (88%) study group participants had progressed to pre-hypertension 
Table 1: Classification of BP
Classification of BP Systolic (mmHg) Diastolic (mmHg)
Normal <120 And<80
Pre-hypertension 120-139 Or 80-89
Stage 1 hypertension 140-159 Or 90-99
Stage 2 hypertension ≥160 Or≥100
BP:	Blood	pressure
Table 2: Distribution of demographic variables among study and 
comparison groups (N=50)






35-37 8 (32.00) 8 (32.00)
38-40 7 (28.00) 7 (28.00)
41-43 7 (28.00) 6 (24.00)
44-45 3 (12.00) 4 (16.00)
2 Marital status
Married 25 (100.00) 25 (100.00)
Unmarried 0 (0) 0 (0)
3 Religion
Christian 6 (24.00) 5 (20.00)
Hindu 15 (60.00) 16 (64.00)
Muslim 4 (16.00) 4 (16.00)
4 Educational status
Primary school 12 (48.00) 8 (32.00)
Middle school 3 (12.00) 7 (28.00)
High school 3 (12.00) 8 (32.00)
Higher secondary school 4 (16.00) 1 (4.00)
Undergraduate 3 (12.00) 1 (4.00)
5 Occupation
Labor 9 (36.00) 11 (44.00)
Farmer 7 (28.00) 5 (20.00)
Government employee 2 (8.00) 1 (4.00)
Private employee 4 (16.00) 4 (16.00)
Business 3 (12.00) 4 (16.00)
6 Dietary	habits
Vegetarian 0 (0) 0 (0)
Non-vegetarian 0 (0) 0 (0)
Mixed 25 (100.00) 25 (100.00)
7 History of smoking
Yes 15 (60.00) 13 (52.00)
No 10 (40.00) 12 (48.00)
8 History of alcoholism
Yes 14 (56.00) 11 (44.00)
No 11 (44.00) 14 (56.00)
9 History of chewing 
tobacco
Yes 12 (48.00) 8 (32.00)
No 13 (52.00) 17 (68.00)
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systolic and 2 (8%) had normal BP. All 25 (100%) study group 
participants had progressed from Stage 1 hypertension-diastolic in the 
pre-test to pre-hypertension diastolic in the post-test.
Out of 25 (100%) comparison group participants, 2 (8%) had 
progressed to Stage 2 hypertension in terms of both systolic and 
diastolic BP, from Stage 1 hypertension, whereas majority of 23 (92%) 
participants were on the same level of Stage 1 hypertension in the post-
test. This emphasized that non-pharmacological measure of cardiac 
walking reduced the BP in spite of antihypertensive medications among 
study group participants because both study and comparison group 
participants received antihypertensive medications. Since cardiac 
walking is a simple measure, patients with hypertension must be 
motivated to practice regularly.
The post-test disclosed that majority of 22 (88%) and 25 (100%) study 
group participants had pre-hypertension of systolic and diastolic BP, 
respectively, in contrast to 23 (92%) comparison group participants 
whose BP was classified under Stage 1 hypertension of both systolic and 
diastolic BP. This proved that cardiac walking had reduced the BP among 
study group. The study group participants had taken antihypertensive 
drugs and also practiced cardiac walking whereas comparison group 
participants had taken only antihypertensive drugs without any non-
pharmacological measures to reduce BP. These findings highlight 
the importance of regular cardiac walking among patients with 
hypertension. These findings are substantiated by the study conducted 
by Lima et al. which revealed that there were immediate 14 mmHg and 
12 mmHg reduction in systolic BP and 4 mmHg in diastolic BP after 
the exercise session for 5 days, which were statistically significant at 
p<0.05 and p<0.01, respectively [4]. Further, the above findings were 
supported by the study conducted by Warner and Louis on the effect 
of 30 minutes walking on BP for 5 days a week. The result showed the 
significant reduction of systolic BP (p<0.01) [5].
The paired t-test value on comparison of pre- and post-test scores of 
systolic and diastolic BPs within the study group revealed statistically 
significant difference at level p<0.001, whereas in comparison group, 
significant difference was not elicited. These findings were further 
supported by the independent t-test, on comparison of post-test 
systolic and diastolic BP between study group and comparison group, 
which disclosed the statistically significant difference at a level of 
p<0.001. The mean value of post-test systolic BP was 129.36 mmHg 
among study group participants, whereas among comparison group, 
it was 142.36 mmHg. The mean value of post-test diastolic BP was 
82.24 mmHg among study group participants, but it was 91.16 mmHg 
among comparison group participants. These differences in the mean 
value of systolic and diastolic BP were due to the effect of cardiac 
walking done by the study group participants.
Table 3: Distribution of biological variables among study and 
comparison groups (N=50)





1 Body mass index (kg/m2)
Underweight (<19) 0 (0) 0 (0)
Ideal weight (19.1-25) 0 (0) 3 (12)
Overweight (25.1-30) 12 (48) 17 (68)
Obese (30.1-35) 12 (48) 4 (16)
Severe obese (35.1-40) 1 (4) 0 (0)
Morbid obese (>40) 0 (0) 1 (4)
2 Duration	of	sleep	(hours/day)
4-5 2 (8) 0 (0)
6-7 9 (36) 7 (28)
8-9 9 (36) 7 (28)
More than 9 5 (20) 11 (44)
3 Waist circumference (cm)
70-75 0 (0) 4 (16)
75.1-80 7 (28) 1 (4)
80.1-85 8 (32) 4 (16)
85.1-90 9 (36) 16 (64)
90.1-95 1 (4) 0 (0)
Table 4: Distribution of clinical variables among study and 
comparison groups (N=50)






Diabetes	mellitus 11 (44) 10 (40)
Osteoarthritis 2 (8) 5 (20)
Hypothyroidism 12 (48) 10 (40)
2 Time since diagnosis (month)
1-10 8 (32) 8 (32)
11-20 14 (56) 16 (64)
21-30 3 (12) 1 (4)
3 Anti-hypertensive medication
Atenolol 10 (40) 11 (44)
Amlong 11 (44) 12 (48)
Propranolol 4 (16) 2 (8)
4 Duration	of	treatment	(months)
1-10 8 (32) 8 (32)
11-20 14 (56) 16 (64)
21-30 3 (12) 1 (4)
5 Random blood glucose (mgs/dl)
100-120 14 (56) 15 (60)
121-140 5 (20) 6 (24)
141-160 1 (4) 0 (0)
161-180 5 (20) 3 (12)
181-200 0 (0) 1 (4)
6 Total cholesterol (mg/dl)
170-180 2 (8) 1 (4)
181-190 10 (40) 9 (36)
191-200 13 (52) 15 (60)
Table 5: Distribution of level of BP in pre- and post-test among 
study group (N=25)
S.No Level of 
BP (mmHg)
Study group N (%)
Pre-test Post-test
Systolic Diastolic Systolic Diastolic
1 Normal 0 (0) 0 (0) 2 (8) 0 (0)
2 Pre-hypertension 0 (0) 0 (0) 22 (88) 25 (100)
3 Stage-1 
hypertension
25 (100) 25 (100) 1 (4) 0 (0)
4 Stage-2 
hypertension
0 (0) 0 (0) 0 (0) 0 (0)
BP:	Blood	pressure
Table 6: Distribution of level of BP in pre- and post-test among 
comparison group (N=25)
S.No Level of 
BP (mmHg)
Comparison group N (%)
Pre-test Post-test
Systolic Diastolic Systolic Diastolic
1 Normal 0 (0) 0 (0) 0 (0) 0 (0)
2 Hypertension 0 (0) 0 (0) 0 (0) 0 (0)
3 Stage-1 
hypertension
25 (100) 25 (100) 23 (92) 23 (92)
4 Stage-2 
hypertension
0 (0) 0 (0) 2 (8) 2 (8)
BP:	Blood	pressure
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In addition, the findings of this study were supported by the study 
conducted by Grassi et al. on the effectiveness of walking exercise 
program in controlling the BP which revealed that, after walking, 
there was a mean reduction of 12 mmHg (p<0.0001) in systolic BP 
and 4 mmHg in diastolic BP in women (p<0.005) [6].Thus it affirms 
that walking exercise reduces blood pressure among patients with 
hypertension.[6].
Many studies have proved the effectiveness of non-pharmacological 
interventions on BP among patients with hypertension. A research 
study conducted by Kandasamy et al. regarding the impact of education 
about lifestyle modification on BP unveiled that there was a statistically 
significant reduction in the BP which also improved the quality of life 
among patients with hypertension [7]. Another study conducted by 
Devi	 and	 Pamba	 disclosed	 that	 Bamboo	 shoots	 are	 very	 effective	 in	
reducing BP among patients with hypertension [8]. This study findings 
are substantiated by the various research findings as quoted above and 
proved	 that	 simple,	 cost-effective	 intervention	 –	 cardiac	walking	 –	 is	
effective in reducing BP among patients with hypertension.
Hence, H1 “There is a significant difference in the systolic and diastolic 
BP among patients with hypertension who had subjected to cardiac 
walking than those who had not” is accepted. In addition to the above 
findings, hypertension causes complication and reduces the life 
expectancy. This is substantiated by the study conducted by Urrutia 
et al. which revealed that males with hypertension, diabetes mellitus, 
family history of cardiovascular diseases, and history of smoking have 
higher risk for heart attack (n=203 [62.08%]) than females, which is 
fatal [9]. Similarly, the uncontrolled BP patients were more likely to be 
males	(odds	ratio=5.03;	95%	confidence	interval:	2.86-8.86;	p<0.001)	
according to the study findings by Soubra et al. [10]. These findings 
insist the importance of non-pharmacological measures to reduce BP 
among patients with hypertension.
CONCLUSION
Cardiac walking is very effective and significantly reduces and maintains 
BP within normal limit among patients with hypertension. Over to this, 
it is a simple, cost-effective measure to maintain normal BP along with 
pharmacological measures. Cardiac walking is an easiest home remedy 
which can be practiced by all patients with hypertension and this will 
prevent the complications related to hypertension.
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Table 7: Comparison of pre- and post-test BP within study and comparison groups (N=50)
S.No Observation Study group Comparison group
Mean±standard deviation Paired “t” value and 
p value
Mean±standard deviation Paired “t” value and 
p value




2 Post-test systolic (mmHg) 129.36±6.67 SS 140.96±1.01 NS




4 Post-test diastolic (mmHg) 82.24±1.85 SS 90.32±1.10 NS
***Significant	at	p<0.001,	NS:	Not	significant,	SS:	Statistically	significant,	BP:	Blood	pressure
Table 8: Comparison of post-test BP between study and 
comparison groups (N=50)
S.No Observation Study group Comparison 
group
“t” value 
and p value
Mean±standard 
deviation
Mean±standard 
deviation
1 Post-test 
systolic  
(mmHg)
129.36±6.67 142.36±4.60 −8.012***
p=0.000
SS
2 Post-test 
diastolic  
(mmHg)
82.24±1.85 91.16±3.53 −11.180***
p=0.000
SS
***Significant	at	p<0.001,	SS:	Statistically	significant,	BP:	Blood	pressure
